Scientists from the British University of Oxford said that they intend to send 5 healthy people to the Netherlands to deliberately inject them in some way of malaria so that its effects can be studied, according to the British Press Agency (BA Media).
They are scheduled to be injected with “Plasmodium FIFAX”, a type of malaria that can remain inherent in the liver. It can also be active again after months or years of the first time the person was hit, causing relapses.
Scientists want the Oxford Group for vaccines to understand more about the infections that are in the months that follow the injury of a person the first time through a mosquito bite.
To do this, scientists will send 5 healthy people to be exposed to bites with a mosquito in a laboratory in the Netherlands. Then they will return to Oxford in Britain, where they will be monitored before being treated to stop the potential setbacks.
Research conditions
“This study is the first of its kind in which the Malaria Vevax infection is entered into healthy volunteers under controlled research conditions.
“Indeed, we aim to answer major questions about setbacks and how the immune system responds to,” she added.
“We know that more than 80% of the global Malaria Vevax is due to a reactive infection and causes great pain in both adults and children in many parts of the world.”
The new study, called “A Mariah Challenge Study”, was launched by Oxford University in cooperation with the Laborat Lab Lab, with the aim of changing the understanding of this type of malaria.
At the end of the 6 -month study period, all participants will be given anti -malaria tablets along with a drug called “premakin” that eliminates parasites inherent in the liver.